134 related articles for article (PubMed ID: 6715702)
1. Platelet-mediated thrombosis in stenosed canine coronary arteries: inhibition by nicergoline, a platelet-active alpha-adrenergic antagonist.
Bolli R; Ware JA; Brandon TA; Weilbaecher DG; Mace ML
J Am Coll Cardiol; 1984 Jun; 3(6):1417-26. PubMed ID: 6715702
[TBL] [Abstract][Full Text] [Related]
2. Influence of alpha-adrenergic blockade on platelet-mediated thrombosis in stenosed canine coronary arteries.
Bolli R; Brandon TA; Mace ML; Weibaecher DG
Cardiovasc Res; 1985 Mar; 19(3):146-54. PubMed ID: 2859114
[TBL] [Abstract][Full Text] [Related]
3. Potentiation by adrenaline of human platelet activation and the inhibition by the alpha-adrenergic antagonist nicergoline of platelet adhesion, secretion and aggregation.
Lanza F; Cazenave JP; Beretz A; Sutter-Bay A; Kretz JG; Kieny R
Agents Actions; 1986 Aug; 18(5-6):586-95. PubMed ID: 3020942
[TBL] [Abstract][Full Text] [Related]
4. Blood flow reductions in stenosed canine coronary arteries: vasospasm or platelet aggregation?
Folts JD; Gallagher K; Rowe GG
Circulation; 1982 Feb; 65(2):248-55. PubMed ID: 7053882
[TBL] [Abstract][Full Text] [Related]
5. Inhibition by nitroglycerin of canine platelet aggregation and cyclic flow reductions in stenosed coronary arteries.
Tanaka T; Morishima Y; Watanabe K; Takahashi M; Shibano T
Methods Find Exp Clin Pharmacol; 1995 Dec; 17(10):693-700. PubMed ID: 9053590
[TBL] [Abstract][Full Text] [Related]
6. The effects of alpha 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries.
Bush LR; Campbell WB; Kern K; Tilton GD; Apprill P; Ashton J; Schmitz J; Buja LM; Willerson JT
Circ Res; 1984 Nov; 55(5):642-52. PubMed ID: 6488486
[TBL] [Abstract][Full Text] [Related]
7. Localized administration of sodium nitroprusside enhances its protection against platelet aggregation in stenosed and injured coronary arteries.
Willerson JT; Igo SR; Yao SK; Ober JC; Macris MP; Ferguson JJ
Tex Heart Inst J; 1996; 23(1):1-8. PubMed ID: 8680268
[TBL] [Abstract][Full Text] [Related]
8. The effects of cigarette smoke and nicotine on platelet thrombus formation in stenosed dog coronary arteries: inhibition with phentolamine.
Folts JD; Bonebrake FC
Circulation; 1982 Mar; 65(3):465-70. PubMed ID: 7055868
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
[TBL] [Abstract][Full Text] [Related]
10. ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries.
Yao SK; Ober JC; McNatt J; Benedict CR; Rosolowsky M; Anderson HV; Cui K; Maffrand JP; Campbell WB; Buja LM
Circ Res; 1992 Jan; 70(1):39-48. PubMed ID: 1727687
[TBL] [Abstract][Full Text] [Related]
11. Effect of thromboxane and serotonin receptor antagonists on intracoronary platelet deposition in dogs with experimentally stenosed coronary arteries.
Golino P; Buja LM; Ashton JH; Kulkarni P; Taylor A; Willerson JT
Circulation; 1988 Sep; 78(3):701-11. PubMed ID: 3409505
[TBL] [Abstract][Full Text] [Related]
12. Platelet aggregation in partially obstructed vessels and its elimination with aspirin.
Folts JD; Crowell EB; Rowe GG
Circulation; 1976 Sep; 54(3):365-70. PubMed ID: 947567
[TBL] [Abstract][Full Text] [Related]
13. Tocotrienols-induced inhibition of platelet thrombus formation and platelet aggregation in stenosed canine coronary arteries.
Qureshi AA; Karpen CW; Qureshi N; Papasian CJ; Morrison DC; Folts JD
Lipids Health Dis; 2011 Apr; 10():58. PubMed ID: 21489303
[TBL] [Abstract][Full Text] [Related]
14. High-dose droperidol protects against experimental coronary thrombosis in dogs and pigs and attenuates aggregation of porcine platelets and Ca2+ mobilization in human platelets.
Bertha BG; Sill JC; Berger I; Folts JD; Milde JH
Anesthesiology; 1993 Apr; 78(4):733-43. PubMed ID: 8466073
[TBL] [Abstract][Full Text] [Related]
15. Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries.
Bush LR; Campbell WB; Buja LM; Tilton GD; Willerson JT
Circulation; 1984 Jun; 69(6):1161-70. PubMed ID: 6546902
[TBL] [Abstract][Full Text] [Related]
16. Liposome-bound prostaglandin E1 often prevents cyclic flow variations in stenosed and endothelium-injured canine coronary arteries.
Willerson JT; Yao SK; McNatt J; Cui K; Anderson HV; Swensen C; Ostro M; Buja LM
Circulation; 1994 Apr; 89(4):1786-91. PubMed ID: 8149544
[TBL] [Abstract][Full Text] [Related]
17. Effects of MDL 28,133A, a 5-HT2 receptor antagonist, on platelet aggregation and coronary thrombosis in dogs.
Hsieh CP; Sakai K; Bruns GC; Dage RC
J Cardiovasc Pharmacol; 1994 Nov; 24(5):761-72. PubMed ID: 7532754
[TBL] [Abstract][Full Text] [Related]
18. [Ultrastructural study on the effect of an inhibitor of platelet aggregation (author's transl)].
Le Menn R; Migne J; Probst-Dvojakovic RJ
Arzneimittelforschung; 1979; 29(8a):1278-82. PubMed ID: 540072
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of acute platelet thrombosis formation in stenosed canine coronary arteries by specific serotonin 5HT2 receptor antagonist ritanserin.
Torr S; Noble MI; Folts JD
Cardiovasc Res; 1990 Jun; 24(6):465-70. PubMed ID: 2117499
[TBL] [Abstract][Full Text] [Related]
20. Abolition of cyclic flow variations in stenosed, endothelium-injured coronary arteries in nonhuman primates with a peptide fragment (VCL) derived from human plasma von Willebrand factor-glycoprotein Ib binding domain.
McGhie AI; McNatt J; Ezov N; Cui K; Mower LK; Hagay Y; Buja LM; Garfinkel LI; Gorecki M; Willerson JT
Circulation; 1994 Dec; 90(6):2976-81. PubMed ID: 7994845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]